BOSTON, Nov. 28 (Reuters) - Millennium Pharmaceuticals Inc (MLNM.O: Quote, Profile, Research) said on Wednesday it is dropping development of its experimental drug for rheumatoid arthritis after it was shown not to be effective in an early clinical trial.
